Chinook Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KDNY and other ETFs, options, and stocks.

About KDNY

Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. 

CEO
Eric L. Dobmeier
CEOEric L. Dobmeier
Employees
138
Employees138
Headquarters
Seattle, Washington
HeadquartersSeattle, Washington
Founded
2000
Founded2000
Employees
138
Employees138

KDNY Key Statistics

Market cap
1.19B
Market cap1.19B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
864.76K
Average volume864.76K
High today
$19.61
High today$19.61
Low today
$18.62
Low today$18.62
Open price
$19.61
Open price$19.61
Volume
577.27K
Volume577.27K
52 Week high
$23.86
52 Week high$23.86
52 Week low
$10.48
52 Week low$10.48

Analyst ratings

100%

of 8 ratings
Buy
100%
Hold
0%
Sell
0%

KDNY Earnings

-$1.24
-$0.78
-$0.32
$0.14
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 7, After Hours
ActualExpected Nov 7, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.